Antagonism by imidazoline - Type drugs of muscarinic and other receptors in the guinea-pig ileum

Autonomic and Autacoid Pharmacology

Volumn 26, Issue 3, 2006, Pages 267-273

  Salazar Bookaman, M M ^a,b   Miller, D D ^c   Patil, P N ^b  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Carbachol; Guinea pig ileum; Histamine and serotonin; Imidazolines; Oxymetazoline; Receptor interaction

Indexed keywords

ACETYLCHOLINE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIHISTAMINIC AGENT; CARBACHOL; CIMETIDINE; CLONIDINE; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; IMIDAZOLINE; METHOXAMINE; MUSCARINIC AGENT; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR; NAPHAZOLINE; OXYMETAZOLINE; PHENTOLAMINE; SEROTONIN; SEROTONIN RECEPTOR; TETRYZOLINE; TOLAZOLINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCULATION; COMPETITIVE INHIBITION; DISSOCIATION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; GUINEA PIG; ILEUM; MALE; MUSCLE CONTRACTION; NONHUMAN; RECEPTOR BLOCKING;

ANIMALS; CARBACHOL; CHOLINERGIC AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; HISTAMINE; ILEUM; IMIDAZOLINES; MALE; METHOXAMINE; MUSCARINIC ANTAGONISTS; MUSCLE CONTRACTION; MUSCLE, SMOOTH; OXYMETAZOLINE; RECEPTORS, HISTAMINE H1; RECEPTORS, SEROTONIN; SEROTONIN;

EID: 33745132095     PISSN: 14748665     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1474-8673.2006.00355.x     Document Type: Article

References (22)

1. ARIËNS E.J. (ed.) ( 1964). Molecular Pharmacology. Academic Press, New York.
2. ARUNLAKSHANA O. SCHILD H.O. ( 1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol., 14, 48 58.
3. BANNING J.W. RICE P.J. MILLER D.D. RUFFOLO R.R. HAMADA A. PATIL P.N. ( 1984). Differences in the adrenoceptor activation by stereo isomeric catecholimidazolines and catecholamines. In : Neuronal and Extraneuronal Events in Autonomic Pharmacology ( Eds W.W. FLEMING S.Z. LANGER K.H. GRAEFE N. WEINER pp. 167 180. Raven Press, New York.
4. BOVET D. ( 1964). The Relations Between Isosterism and Competitive Phenomenon in the Field of Drug Therapy of the Autonomic Nervous System and that of the Neuromuscular Transmission. Nobel Lectures' Physiology and Medicine, pp. 552. Elsevier, New York.
5. BURNSTOCK G. ( 1975). Comparative studies of purinergic nerves. J. Exp. Zoology, 194, 103 134.
6. EHLERT F.J. GRIFFIN M.T. SAWYER G.W. BAILON R. ( 1999). A simple method for estimation of agonist activity at receptors subtypes: comparison of native and cloned M3 muscarinic receptors in guinea-pig ileum and transfected cells. J. Pharmacol. Expt. Ther., 289, 981 992.
7. FOYE W.O. LEMKE T. WILLIAMS D. ( 1995). Principles of Medicinal Chemistry, 4th edn, p. 25. Williams and Wilkins, Baltimore.
8. FRIEDMAN H.L. ( 1951). Influence of Isosteric Replacement upon Biological Activity. National Academy of Sciences, National Research Council Publication No. 206. p. 251. U.S. Government Printing Office, Washington, DC, USA.
9. FURCHGOTT R.F. ( 1967). The pharmacological differentiation of adrenergic receptors. Ann. N. Y. Acad. Sci., 139, 553 570.
10. HOYER D. CLARKE D.E. FOZARD J.R. HARTIG P.R. MARTIN G.R. MYLECHARANE E.J. SAXENA P.R. HUMPHREY P.A. ( 1994). International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 46, 157 203.
11. JING L. MILLER D.D. PATIL P.N. ( 1998). Alpha-adrenergic and serotonergic actions of oxymetazoline in the rat aorta. Pharmacol. Rev. Comm., 10, 51 58.
12. KILBINGER H. WOLF D. ( 1998). Effects of 5HT4 receptors stimulation on basal and electrically evoked release of acetylcholine from guinea-pig myenteric plexus. Naunyn-Schmiedeberg's Arch. Pharmacol., 345, 270 275.
13. MUJIC M. VAN ROSSUM J.M. ( 1965). Comparative pharmacodynamics of sympathomimetic imidazolines; studies on intestinal smooth muscle of the rabbit and the cardiovascular system of the cat. Arch. Int. Pharmacodyn., 155, 432 449.
14. PATIL P.N. ISHIKAWA H. ( 2004). Antimuscarinic action of oxymetazoline on human intra-ocular muscles. J. Ocular Pharmacol. Ther., 20, 328 332.
15. REIS D. BOUSQUET P. PARINI A. (eds.) ( 1995). The imidazolines receptor: pharmacology, functions, ligands and relevance to biology and medicine. Ann. N.Y. Acad. Sci., 763, 1 707.
16. RUFFOLO R.R. TUROWSKI B.S. PATIL P.N. ( 1977). Lack of cross-desensitization between structurally dissimilar α-adrenoceptor agonists. J. Pharm. Pharmacol., 29, 378 380.
17. SANDERS J. MILLER D.D. PATIL P.N. ( 1975). Alpha adrenergic and histaminergic effects of tolazoline-like imidazolines. J. Pharmacol. Expl. Ther., 195, 362 371.
18. SCHACHTER M. ( 1952). The release of histamine by pethidine, atropine and other drugs. Br. J. Pharmacol Chemother., 7, 646 654.
19. SENGUPTA J.N. HAMADA A. MILLER D.D. PATIL P.N. ( 1987). Interaction of enantiomers of hydroxy tolazoline with adrenoceptor. Naunyn-Schmiedeberg's Arch. Pharmacol., 335, 391 396.
20. THOMAS E.A. BAKER S.A. EHLERT F.J. ( 1993). Functional role for the M2 muscarinic receptor in smooth muscle of guinea-pig ileum. Mol. Pharmacol., 44, 102 110.
21. TRIPOD J. ( 1949). Some relationships between anti-nicotine activity and specific antagonisms. Bri. J. Pharmacol., 4, 323 328.
22. XUAN B. CHIOU G.C.Y. ( 1997). Efficacy of oxymetazoline in non-infectious conjunctivitis, the most common cause of acute red eyes. J. Ocular Pharmacol. Ther., 13, 363 367.